Risk factors for the persistence of respiratory symptoms in childhood asthma (Q34246831)

31 July 2017

title

Risk factors for the persistence of respiratory symptoms in childhood asthma. (English)

1 reference

31 July 2017

0 references

Bahçeciler NN

1

1 reference

31 July 2017

Barlan IB

series ordinal

2

1 reference

31 July 2017

Nuhoğlu Y

series ordinal

3

1 reference

31 July 2017

Başaran MM

series ordinal

4

1 reference

31 July 2017

publication date

1 April 2001

1 reference

Annals of Allergy, Asthma & Immunology

31 July 2017

published in

1 reference

31 July 2017

volume

86

1 reference

31 July 2017

issue

4

1 reference

31 July 2017

page(s)

449-455

1 reference

Risk factors for the persistence of respiratory symptoms in childhood asthma

31 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016/S1081-1206(10)62494-5

7 January 2021

A prospective study of the natural history of asthma. Remission and relapse rates

1 reference

https://api.crossref.org/works/10.1016/S1081-1206(10)62494-5

7 January 2021

Outcome of wheeze in childhood. Symptoms and pulmonary function 25 years later

1 reference

https://api.crossref.org/works/10.1016/S1081-1206(10)62494-5

7 January 2021

Prognosis of asthma from childhood to adulthood

1 reference

https://api.crossref.org/works/10.1016/S1081-1206(10)62494-5

7 January 2021

Childhood asthma in adult life: a further study at 28 years of age

1 reference

https://api.crossref.org/works/10.1016/S1081-1206(10)62494-5

7 January 2021

Factors in childhood as predictors of asthma in adult life

1 reference

https://api.crossref.org/works/10.1016/S1081-1206(10)62494-5

7 January 2021

Childhood asthma and adult lung function

1 reference

https://api.crossref.org/works/10.1016/S1081-1206(10)62494-5

7 January 2021

Ventilatory function in British adults after asthma or wheezing illness at ages 0-35.

1 reference

https://api.crossref.org/works/10.1016/S1081-1206(10)62494-5

7 January 2021

Efficacy and safety of inhaled corticosteroids. New developments

1 reference

https://api.crossref.org/works/10.1016/S1081-1206(10)62494-5

7 January 2021

Effect of long-term treatment with inhaled corticosteroids and beta-agonists on the bronchial responsiveness in children with asthma

1 reference

https://api.crossref.org/works/10.1016/S1081-1206(10)62494-5

7 January 2021

The effect of drug therapy on long-term outcome of childhood asthma: a possible preview of the international guidelines

1 reference

https://api.crossref.org/works/10.1016/S1081-1206(10)62494-5

7 January 2021

Effects of long-term treatment with an inhaled corticosteroid on growth and pulmonary function in asthmatic children

1 reference

https://api.crossref.org/works/10.1016/S1081-1206(10)62494-5

7 January 2021

Effects of 22 months of treatment with inhaled corticosteroids and/or beta-2-agonists on lung function, airway responsiveness, and symptoms in children with asthma. The Dutch Chronic Non-specific Lung Disease Study Group

1 reference

https://api.crossref.org/works/10.1016/S1081-1206(10)62494-5

7 January 2021

Comparison of a beta 2-agonist, terbutaline, with an inhaled corticosteroid, budesonide, in newly detected asthma

1 reference

https://api.crossref.org/works/10.1016/S1081-1206(10)62494-5

7 January 2021

The natural history of respiratory symptoms in a cohort of adolescents

1 reference

https://api.crossref.org/works/10.1016/S1081-1206(10)62494-5

7 January 2021

Third International Pediatric Consensus statement on the management of childhood asthma. International Pediatric Asthma Consensus Group

1 reference

https://api.crossref.org/works/10.1016/S1081-1206(10)62494-5

7 January 2021

Prognostic factors for the outcome of childhood asthma in adolescence

1 reference

https://api.crossref.org/works/10.1016/S1081-1206(10)62494-5

7 January 2021

10.1016/S1081-1206(10)62494-5

Identifiers

DOI

1 reference

31 July 2017

1 reference